We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Thermo Strengthens Bioprocessing Offering with Advanced Scientifics Acquisition
News

Thermo Strengthens Bioprocessing Offering with Advanced Scientifics Acquisition

Thermo Strengthens Bioprocessing Offering with Advanced Scientifics Acquisition
News

Thermo Strengthens Bioprocessing Offering with Advanced Scientifics Acquisition

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Thermo Strengthens Bioprocessing Offering with Advanced Scientifics Acquisition"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

ASI designs, manufactures and delivers customized single-use systems and equipment for the preparation, processing, storage and transportation of biopharmaceuticals. The company has 380 employees and operations in Pennsylvania and Mexico.

“ASI’s intense customer focus has led to the development of innovative solutions that complement our existing single-use technologies and expand our offering across the bioprocessing workflow,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “We see this acquisition as a great opportunity to meet customer demand for quality and productivity in bioprocessing, and plan to leverage our global reach to bring these innovative products to a larger customer base.”

Advanced Scientifics had approximately $80 million in 2014 revenue and will be integrated into Thermo Fisher’s Life Sciences Solutions Segment. The company expects accretion to its adjusted earnings per share from the acquisition to be immaterial.

Advertisement